Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

TSXV:ADK - Post Discussion

Diagnos Inc > Are we cash flow Positive???
View:
Post by hotginger on Jun 22, 2022 1:07pm

Are we cash flow Positive???

DIAGNOS has a high-margin SaaS model; it only costs ~4 cents to process an image that it charges between ~C$5 - $10, this represents a 12,500% gross profit margin at $5. DIAGNOS does not sell the software, it protects its proprietary code and database, the software resides in its servers, and everywhere the CARA platform solution is set up it functions as a service.  In the Company’s latest Corporate Update, issued January 26, 2022, DIAGNOS stated “The Company’s accomplishments in 2021 were truly transformational and have positioned DIAGNOS for success in 2022. Our team at DIAGNOS is committed to the task at hand; delivering growth and value for all shareholders. The Company anticipates being cashflow positive by the end of June 2022.”
 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities